Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Go back to Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update| (NASDAQ: FENC) | Delayed: 10.30 +0.77 (8.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.53 | 52 Week High | $ | |||
| Open | $9.33 | 52 Week Low | $ | |||
| Day High | $10.58 | P/E | N/A | |||
| Day Low | $9.33 | EPS | $ | |||
| Volume | 377,792 | |||||
| Forest Laboratories (NYSE: FRX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $100.88 | |||
| Open | $24.87 | 52 Week Low | $64.33 | |||
| Day High | $12.00 | P/E | 20.69 | |||
| Day Low | $12.00 | EPS | $0.58 | |||
| Volume | 20 | |||||
